0001209191-20-047455.txt : 20200819 0001209191-20-047455.hdr.sgml : 20200819 20200819141136 ACCESSION NUMBER: 0001209191-20-047455 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200817 FILED AS OF DATE: 20200819 DATE AS OF CHANGE: 20200819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sharp Shalini CENTRAL INDEX KEY: 0001377202 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 201116599 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-17 0 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001377202 Sharp Shalini C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949 0 1 0 0 CFO & Executive Vice President Common Stock 2020-08-17 4 S 0 461 88.24 D 100747 D Common Stock 2020-08-17 4 S 0 2560 88.54 D 98187 D Common Stock 2020-08-17 4 M 0 500 70.57 A 98687 D Common Stock 2020-08-17 4 S 0 500 88.38 D 98187 D Common Stock 2020-08-17 4 M 0 7188 67.55 A 105375 D Common Stock 2020-08-17 4 S 0 7188 88.38 D 98187 D Common Stock 2020-08-17 4 M 0 3669 48.43 A 101856 D Common Stock 2020-08-17 4 S 0 3669 88.38 D 98187 D Stock Option (Right to Buy) 70.57 2020-08-17 4 M 0 500 0.00 D 2026-06-01 Common Stock 500 0 D Stock Option (Right to Buy) 67.55 2020-08-17 4 M 0 7188 0.00 D 2029-03-01 Common Stock 7188 15812 D Stock Option (Right to Buy) 48.43 2020-08-17 4 M 0 3669 0.00 D 2028-03-01 Common Stock 3669 15312 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.45 to $88.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.17 to $88.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. 1/4th of the option vested one year from June 1, 2016 and then 1/48th of the option vested monthly thereafter. 1/4th of the option vested one year from March 1, 2019 and then 1/48th of the option vested monthly thereafter. 1/4th of the option vested one year from March 1, 2018 and then 1/48th of the option vested monthly thereafter. /s/ Karah Parschauer, attorney-in-fact 2020-08-19